Kempharm Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Kempharm Inc
TickerZVRA
CIK #0001434647
CUSIP488445206
SectorLife Sciences - Pharmaceutical Preparations
Address2656 Crosspark Road, Suite 100, Coralville, IA 52241
Source [EDGAR]
CIK Filing 2011 - 2025
[0001434647] 10-K
[0001434647] 10-Q
[0001434647] 3
[0001434647] 4
[0001434647] 8-K
[0001434647] D
[0001434647] SC 13D
[0001434647] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Adage Capital Management LP Zevra Therapeutics Inc [2025-02-12] 0.0
Woodline Partners LP Zevra Therapeutics Inc [2024-11-14] 7.7
Nantahala Capital Management LLC Zevra Therapeutics Inc [2024-02-14] 6.2
BlackRock Inc Zevra Therapeutics Inc [2024-01-29] 5.8
BlackRock Inc Kempharm Inc [2022-07-08] 2.5
BlackRock Inc Kempharm Inc [2022-02-04] 6.3
Braun Samuel J Kempharm Inc [2021-12-01] 0.6
Braun Samuel J Kempharm Inc [2021-04-19] 7.2
Auctus Fund LLC Kempharm Inc [2021-02-05] 8.58
Empery Asset Management LP Kempharm Inc [2021-01-14] 0.99
Mangless Daniel John Kempharm Inc [2019-06-11] 5.3
Alyeska Investment Group LP Kempharm Inc [2017-02-14] 6.8
Mickle Travis C Kempharm Inc [2016-02-16] 15.5
Delaware Street Capital Master Fund LP Kempharm Inc [2015-10-28] 5.6
Broadfin Capital LLC Kempharm Inc [2015-04-29] 6.0
Flynn James E Kempharm Inc [2015-04-23] 3.71
Form 3/4/5 Filer 2011 - 2025
Zevra Therapeutics Inc
Bode John B
Thompson Rahsaan
Shih Alvin
Dixon Wendy L
Calder Douglas W
Watton Corey Michael
Favorito Tamara A
Anderson Thomas
Quartel Adrian W
Schafer Joshua
McFarlane Neil F.
Clifton R. LaDuane
Sangiovanni Timothy J.
Mickle Christal M M
Guenther Sven
Saluri Joseph
Plooster Matthew R
Tierney David S
Pascoe Richard W
Posner Christopher
Mickle Travis C
Braun Samuel J
Johnson Gordon K
Thompson Danny L
DSC Advisors, L.L.C.
DSC Advisors, L.P.
Bluhm Andrew G
Delaware Street Capital Master Fund, L.P.
DSC Managers, L.L.C.
Cohen Daniel L
Woody Tracy M
Form 13F Holdings
Firm Period DFND Voting Shares
Woodline Partners LP [2025-06-30] SOLE 4,615,676 4,615,676
Adage Capital Partners GP LLC [2025-06-30] SOLE 4,168,000 4,168,000
BlackRock, Inc. [2025-06-30] SOLE 4,001,236 4,081,544
Vanguard Group Inc [2025-06-30] SOLE 0 2,879,963
FMR LLC [2025-06-30] DFND 2,277,374 2,289,243
Rubric Capital Management LP [2025-06-30] SOLE 1,958,318 1,958,318
Nantahala Capital Management LLC [2025-06-30] SOLE 1,471,936 1,471,936
Geode Capital Management LLC [2025-06-30] DFND 1,242,386 1,242,386
State Street Corp [2025-06-30] DFND 1,169,431 1,241,658
683 Capital Management LLC [2025-06-30] DFND 1,125,000 1,125,000
Legal & General Group Plc [2025-06-30] DFND 935,677 935,677
Susquehanna International Group LLP [2025-06-30] OTR 161,493 783,093
Stonepine Capital Management LLC [2025-06-30] SOLE 775,620 775,620
Velan Capital Investment Management LP [2025-06-30] SOLE 715,000 715,000
AIGH Capital Management LLC [2025-06-30] SOLE 683,244 683,244
Millennium Management LLC [2025-06-30] SOLE 634,820 634,820
Retirement Planning Co of New England, Inc. [2025-06-30] SOLE 0 553,297
Kingdon Capital Management LLC [2025-06-30] DFND 450,000 450,000
Northern Trust Corp [2025-06-30] DFND 416,891 416,891
Goldman Sachs Group Inc [2025-06-30] DFND 374,552 374,792
Mystic Asset Management Inc [2025-06-30] SOLE 0 346,652
Schroder Investment Management Group [2025-06-30] SOLE 315,469 315,469
Jane Street Group LLC [2025-06-30] DFND 183,104 298,604
Janney Montgomery Scott LLC [2025-06-30] SOLE 256,664 256,664
AIGH Capital Management LLC [2025-06-30] OTR 0 235,649
Propel Bio Management LLC [2025-06-30] DFND 84,874 231,874
Bank of America Corp /DE/ [2025-06-30] DFND 8,988 223,852
Stratos Wealth Partners Ltd [2025-06-30] SOLE 0 220,000
Morgan Stanley [2025-06-30] DFND 209,132 213,088
D. E. Shaw & Co., Inc. [2025-06-30] DFND 189,313 189,313
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com